-- ResMed (RMD) has an average rating of overweight and mean price target of $305.30, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Price: $228.56, Change: $-0.31, Percent Change: -0.14%